U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Hydromorphone Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 10/31/2017
»Therapeutic Categories: Analgesia/Addiction

Expand all

Fresenius Kabi USA, LLC (Reverified 09/04/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 1 mg/1 mL (NDC 63323-852-25) Unavailable Backordered. Next release September 2024. Check wholesaler for inventory. Demand increase for the drug
Injection, 2 mg/1 mL (NDC 63323-853-25) Unavailable Backordered. Next release September 2024; Check wholesalers for inventory Demand increase for the drug
Injection, 4 mg/1 mL (NDC 63323-854-10) Available Check wholesalers for inventory
Injection, 10 mg/1 mL (NDC 63323-851-10) Unavailable Backordered. Next release September 2024. Check wholesalers for inventory. Demand increase for the drug
Injection, 10 mg/1 mL (NDC 63323-851-15) Unavailable Backordered. Next release August 2024; Check wholesalers for inventory. Delay in shipping of the drug
Injection, 10 mg/1 mL (NDC 63323-851-50) Unavailable Backordered. Next release not available at this time. Check wholesaler for inventory. Demand increase for the drug
Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) Unavailable Backordered. Next release September 2024. Check wholesaler for inventory. Demand increase for the drug
Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) Available Check wholesalers for inventory
Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) Unavailable Backordered. Next release not available at this time. Check wholesaler for inventory. Demand increase for the drug
Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) Unavailable Backordered. Next release August 2024. Check wholesalers for inventory. Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 08/28/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Hydromorphone HCl Injection, USP, Injection, 2 mg/1 mL (NDC 0641-0121-25) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.
Hydromorphone HCl Injection, USP, Injection, 2 mg/1 mL (NDC 0641-2341-41) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Revised 08/26/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 2 mg/1 mL (NDC 0409-3365-10) Unavailable Next Delivery: January 2025; Estimated Recovery: March 2025 Delay in shipping of the drug
Injection, 1 mg/1 mL (NDC 0409-1283-37) Unavailable Next Delivery: October 2024; Estimated Recovery: December 2024 Delay in shipping of the drug
Injection, 2 mg/1 mL (NDC 0409-1312-36) Unavailable Next Delivery: November 2024; Estimated Recovery: December 2024 Delay in shipping of the drug
Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) Limited Availability Limited Supply Available; Estimated Recovery: December 2024 Other
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) Limited Availability Limited Supply Available; Estimated Recovery: September 2024 Other
Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) Available

Dear Customer Letter (HYPERLINK)

Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-2552-01) Unavailable Next Delivery and Estimated Recovery: June 2025 Other
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) Unavailable Next Delivery: January 2025; Estimated Recovery: March 2025 Other
Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) Unavailable Next Delivery: January 2025; Estimated Recovery: March 2025 Other
Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) Unavailable Next Delivery: January 2025; Estimated Recovery: March 2025 Other

Teva Pharmaceuticals USA, Inc. (Revised 08/23/2024)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0110-03) Unavailable Estimated recovery TBD Demand increase for the drug
Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0113-03) Unavailable Estimated recovery TBD Demand increase for the drug
Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0018-01) Unavailable Estimated recovery TBD Other
Back to Top